F10 and atrial fibrillation: Since June 19th, 2015, the direct factor Xa inhibitor edoxaban has been approved for stroke prevention in AF in Germany [7] after it has shown to be at least as effective and safer as the VKA warfarin in the pivotal ENGAGE AF-TMI 48 trial [8].